Literature DB >> 20429413

FOXP3 and its role in the immune system.

Chang H Kim1.   

Abstract

FOXP3 is a member of the forkhead transcription factor family. Unlike other members, it is mainly expressed in a subset of CD4+ T-cells that play a suppressive role in the immune system. A function of FOXP3 is to suppress the function of NFAT and NFkappaB and this leads to suppression ofexpression of many genes including IL-2 and effector T-cell cytokines. FOXP3 acts also as a transcription activator for many genes induding CD2S, Cytotoxic T-Lymphocyte Antigen 4 (CTLA4), glucocorticoid-induced TNF receptorfamily gene (GITR) andfolate receptor 4. FOXP3+ T-cells are made in the thymus and periphery. The FOXP3+ T-cells made in the thymus migrate to secondary lymphoid tissues and suppress antigen priming of lymphocytes. Antigen priming of naive FOXP3 T-cdlls and naive FOXP3 T-cells leads to generation of memory FOXP3+ T-cells which are efficient in migration to nonlymphoid tissues. Memory FOXP3+ T-cells are, therefore, effective in suppression of effector T-cell function, while naive FOXP3 T-cells are adept at suppressing the early immune responses in lymphoid tissues. Both naive and memory FOXP3 T-cells are required for effective maintenance of tolerance and prevention of autoimmune diseases throughout the body. Many factors such as cytokines and noncytokine factors regulate the generation of FOXP3 T-cells. For example, retinoic acid, produced by the dendritic cells and epithelial cells in the intestine, works together with TGF-beta1 and promotes generation of small intestine-homing FOXP3 T-cells by upregulating the expression ofFOXP3 and gut homing receptors. FOXP3+ T-cells can be produced in vitro from autologous naive T-cells and, therefore, have great therapeutic potentials in treating a number of inflammatory diseases and grafi rejection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20429413     DOI: 10.1007/978-1-4419-1599-3_2

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  27 in total

1.  [New aspects of current therapeutic strategies in oropharyngeal carcinoma: highlights of the 2012 ASCO meeting].

Authors:  M Loewenthal; E Vitez; S Laban; A Münscher; B Güldenzoph; R Knecht; C-J Busch
Journal:  HNO       Date:  2012-11       Impact factor: 1.284

Review 2.  The dual role of the X-linked FoxP3 gene in human cancers.

Authors:  Margaret Redpath; Bin Xu; Leon C van Kempen; Alan Spatz
Journal:  Mol Oncol       Date:  2011-03-30       Impact factor: 6.603

3.  Progesterone suppresses the mTOR pathway and promotes generation of induced regulatory T cells with increased stability.

Authors:  Jee H Lee; John P Lydon; Chang H Kim
Journal:  Eur J Immunol       Date:  2012-08-06       Impact factor: 5.532

Review 4.  Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.

Authors:  Taekil Eom; Yong Sung Kim; Chang Hwan Choi; Michael J Sadowsky; Tatsuya Unno
Journal:  J Microbiol       Date:  2018-02-28       Impact factor: 3.422

5.  Sodium Selenite Diminished the Regulatory T Cell Differentiation In Vitro.

Authors:  E E Uresti-Rivera; G Méndez-Frausto; M N Medina-Rosales; J Ventura-Juárez; M H García-Hernández
Journal:  Biol Trace Elem Res       Date:  2022-04-29       Impact factor: 3.738

6.  An alternative role for Foxp3 as an effector T cell regulator controlled through CD40.

Authors:  Gisela M Vaitaitis; Jessica R Carter; Dan M Waid; Michael H Olmstead; David H Wagner
Journal:  J Immunol       Date:  2013-06-17       Impact factor: 5.422

7.  Sex-Specific Linear Polyubiquitination Is a Critical Regulator of Contextual Fear Memory Formation.

Authors:  Madeline Musaus; Kayla Farrell; Shaghayegh Navabpour; W Keith Ray; Richard F Helm; Timothy J Jarome
Journal:  Front Behav Neurosci       Date:  2021-07-09       Impact factor: 3.558

8.  Optimal population of FoxP3+ T cells in tumors requires an antigen priming-dependent trafficking receptor switch.

Authors:  Chuanwu Wang; Jee H Lee; Chang H Kim
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

9.  Significant association between FOXP3 gene polymorphism and steroid-resistant acute rejection in living donor liver transplantation.

Authors:  Sapana Verma; Yuka Tanaka; Seiichi Shimizu; Naoki Tanimine; Hideki Ohdan
Journal:  Hepatol Commun       Date:  2017-06-08

10.  The sexist behaviour of immune checkpoint inhibitors in cancer therapy?

Authors:  Andrea Botticelli; Concetta Elisa Onesti; Ilaria Zizzari; Bruna Cerbelli; Paolo Sciattella; Mario Occhipinti; Michela Roberto; Francesca Di Pietro; Adriana Bonifacino; Michele Ghidini; Patrizia Vici; Laura Pizzuti; Chiara Napoletano; Lidia Strigari; Giulia D'Amati; Federica Mazzuca; Marianna Nuti; Paolo Marchetti
Journal:  Oncotarget       Date:  2017-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.